CGH
PAHC icon

Crossmark Global Holdings’s Phibro Animal Health PAHC Stock Holding History

Crossmark Global Holdings’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-7,220
Closed -$310K – 1511
2018
Q3 		$310K Buy
7,220
+160
+2% +$7.56K 0.01% 1291
2018
Q2 		$325K Buy
7,060
+350
+5% +$15.5K 0.01% 1243
2018
Q1 		$266K Sell
6,710
-830
-11% -$30.7K 0.01% 1348
2017
Q4 		$253K Buy
+7,540
New +$268K 0.01% 1472

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Crossmark Global Holdings's PAHC Position: Q4 2018 in Review

Crossmark Global Holdings sold out of Phibro Animal Health (PAHC) in Q4 2018, closing a stake of 7,220 shares — an estimated $310K sold.

Crossmark Global Holdings first reported a position in PAHC in Q4 2017 and held it in 4 quarters. The position peaked at $325K in Q2 2018. 191 funds tracked by Wall St. Rank hold PAHC as of Q4 2018.

  • Crossmark Global Holdings reported no remaining Phibro Animal Health position as of Q4 2018 after selling out during the quarter.
  • Crossmark Global Holdings sold 7,220 Phibro Animal Health shares in Q4 2018, an estimated $310K.
  • Crossmark Global Holdings first reported a position in Phibro Animal Health in Q4 2017 and held it in 4 quarters.
  • Crossmark Global Holdings's Phibro Animal Health position peaked at $325K in Q2 2018.
  • 191 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2018.

Based on Crossmark Global Holdings's 13F filing for Q4 2018, filed 31 Jan 2019.